Login to Your Account

BIO Asia 2018

TOKYO - Following more than a decade of mostly steady progress on Japan's drug regulation and business development fronts, dangers to well-compensated therapeutic innovation are creeping ever-forward in the important Asian market, industry representatives warned.

more »

Our Habitat for All Things Science
GWAS in Chinese population implicates immune system in Alzheimer's disease

A study has identified common genetic variants in the Chinese population contributing to the risk of developing Alzheimer's disease (AD) that possibly exert functional effects through the immune system, which could have important implications for AD management.

The search continues for promising biomarkers and effective disease-modifying therapies for AD. The current drug development approaches mainly target the disease's hallmark pathology of amyloid-beta (Abeta) protein accumulation in the brain leading to Abeta plaque deposition.



Partners in Focus